These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3473 related articles for article (PubMed ID: 11742414)

  • 1. Biochemistry and molecular cell biology of diabetic complications.
    Brownlee M
    Nature; 2001 Dec; 414(6865):813-20. PubMed ID: 11742414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of hyperglycemia in the development of diabetic microangiopathy].
    Miyata S; Kasuga M
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():45-51. PubMed ID: 15999684
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.
    Yamagishi S; Takeuchi M; Inagaki Y; Nakamura K; Imaizumi T
    Int J Clin Pharmacol Res; 2003; 23(4):129-34. PubMed ID: 15224502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.
    Friedman EA
    Diabetes Care; 1999 Mar; 22 Suppl 2():B65-71. PubMed ID: 10097902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of oxidative stress in diabetic vascular complications].
    Inoguchi T; Takayanagi R
    Fukuoka Igaku Zasshi; 2008 Mar; 99(3):47-55. PubMed ID: 18536327
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hyperglycemia and atherosclerosis].
    Wautier JL
    Journ Annu Diabetol Hotel Dieu; 2000; ():107-12. PubMed ID: 10932873
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperglycemia and microangiopathy. Direct regulation by glucose of microvascular cells.
    Kreisberg JI
    Lab Invest; 1992 Oct; 67(4):416-26. PubMed ID: 1434526
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of hyperglycemia and hyperinsulinemia in the pathogenesis of diabetic angiopathy.
    Haller H; Drab M; Luft FC
    Clin Nephrol; 1996 Oct; 46(4):246-55. PubMed ID: 8905209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular disease and late diabetic complications].
    Madsbad S; Brock B; Schmitz O
    Ugeskr Laeger; 2003 Aug; 165(33):3149-53. PubMed ID: 12968409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of mitochondrial ROS production on diabetic vascular complications.
    Nishikawa T; Kukidome D; Sonoda K; Fujisawa K; Matsuhisa T; Motoshima H; Matsumura T; Araki E
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S41-5. PubMed ID: 17452060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms linking diabetes mellitus to the development of atherosclerosis: a role for endoplasmic reticulum stress and glycogen synthase kinase-3.
    Robertson LA; Kim AJ; Werstuck GH
    Can J Physiol Pharmacol; 2006 Jan; 84(1):39-48. PubMed ID: 16845889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes (review).
    Srivastava AK
    Int J Mol Med; 2002 Jan; 9(1):85-9. PubMed ID: 11745003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglycemia and the pathobiology of diabetic complications.
    Aronson D
    Adv Cardiol; 2008; 45():1-16. PubMed ID: 18230953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.
    Rolo AP; Palmeira CM
    Toxicol Appl Pharmacol; 2006 Apr; 212(2):167-78. PubMed ID: 16490224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cellular and molecular mechanisms of diabetic complications.
    King GL; Brownlee M
    Endocrinol Metab Clin North Am; 1996 Jun; 25(2):255-70. PubMed ID: 8799700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiological mechanisms of diabetic angiopathy.
    Hammes HP
    J Diabetes Complications; 2003; 17(2 Suppl):16-9. PubMed ID: 12623164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of protein kinase C might be harmful to diabetic retinopathy.
    Yamagishi S; Takeuchi M
    Med Hypotheses; 2004; 63(1):135-7. PubMed ID: 15193366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvascular complications of diabetes.
    He Z; King GL
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):215-38, xi-xii. PubMed ID: 15053904
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis.
    Rahman S; Rahman T; Ismail AA; Rashid AR
    Diabetes Obes Metab; 2007 Nov; 9(6):767-80. PubMed ID: 17924861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of hyperglycaemia in type 2 diabetes.
    Yki-Järvinen H
    Diabetes Metab Rev; 1998 Sep; 14 Suppl 1():S45-50. PubMed ID: 9816487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 174.